Trends in compliance with two-dose influenza vaccine recommendations among children aged 6 months through 8 years

被引:11
作者
Pabst, Laura J. [1 ]
Chaves, Sandra S. [1 ]
Weinbaum, Cindy [1 ]
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA
关键词
Vaccination; Influenza; Information systems; IMMUNOGENICITY; PERSPECTIVES;
D O I
10.1016/j.vaccine.2013.04.080
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Children aged <9 years may require two doses of influenza vaccine to achieve an adequate immune response to protect against the disease. We analyzed data for >2 million children in each influenza season from 2007 to 2012 from eight Immunization Information System Sentinel Sites to assess trends in two-dose compliance. Compliance was calculated by influenza season, age group, and influenza vaccination history. Two-dose compliance increased from 49% to 60% among 6-23 month olds from 2007 to 2012; no increase was observed for 2-4 or 5-8 year olds. In each season, compliance was 3-12 times higher among 6-23 month olds compared to older children and was two times higher among influenza vaccine naive children compared to previously vaccinated children. Improved messaging for providers and parents about the importance of the two-dose recommendation, about which children are eligible for two doses, and provider access to complete influenza vaccination histories for all children are needed. Published by Elsevier Ltd.
引用
收藏
页码:3116 / 3120
页数:5
相关论文
共 50 条
  • [21] Immunogenicity and Safety of One versus Two Doses of Quadrivalent Inactivated Influenza Vaccine (IIV4) in Vaccine-Unprimed Children and One Dose of IIV4 in Vaccine-Primed Children Aged 3-8 Years
    Shi, Yunfeng
    Yang, Wanqi
    Li, Xiaoyu
    Chu, Kai
    Wang, Jianfeng
    Tang, Rong
    Xu, Li
    Li, Lanshu
    Hu, Yuansheng
    Zhao, Chenyan
    Pan, Hongxing
    VACCINES, 2023, 11 (10)
  • [22] Coverage and parental perceptions of influenza vaccination among parents of children aged 6 to 23 months in Hong Kong
    Lau, Joseph T. F.
    Mo, Phoenix K. H.
    Cai, Yan Shan
    Tsui, Hi Yi
    Choi, Kai Chow
    BMC PUBLIC HEALTH, 2013, 13
  • [23] The immunogenicity and safety of a single 0.5 mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to &lt;36 months: Data from a randomized, Phase III study
    Esposito, Susanna
    Marchisio, Paola
    Montinaro, Valentina
    Bianchini, Sonia
    Weverling, Gerrit Jan
    Pariani, Elena
    Amendola, Antonella
    Fabiano, Valentina
    Pivetti, Valentina
    Zanetti, Alessandro
    Zuccotti, Gian Vincenzo
    VACCINE, 2012, 30 (49) : 7005 - 7012
  • [24] Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2-6 years in Germany
    Falkenhorst, G.
    Harder, T.
    Remschmidt, C.
    Terhardt, M.
    Zepp, F.
    Ledig, T.
    Wicker, S.
    Keller-Stanislawski, B.
    Mertens, T.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2013, 56 (11) : 1557 - 1564
  • [25] A Potential Platform for Future Vaccine Trials Identifies a High Incidence of Symptomatic and Asymptomatic Influenza Infection Among Children Aged 6 to 23 Months in South Africa
    Cohen, Cheryl
    du Plessis, Mignon
    Martinson, Neil
    Moyes, Jocelyn
    Walaza, Sibongile
    Wolter, Nicole
    Makhasi, Mvuyo
    Moosa, Fahima
    Charles, Myrna
    Samuels, Aaron M.
    Tempia, Stefano
    Moloantoa, Tumelo
    Ncwana, Bekiwe
    Phalatse, Louisa
    Buys, Amelia
    Fry, Alicia
    Baumgartner, Eduardo Azziz
    von Gottberg, Anne
    Kleynhans, Jackie
    JOURNAL OF INFECTIOUS DISEASES, 2024, : e328 - e336
  • [26] Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis
    Wei, Xia
    Tan, Xue
    Guan, Qinghu
    Zhang, Ruizhi
    Lei, Shiguang
    Wei, Shaofeng
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [27] Post-Marketing Safety Surveillance of Quadrivalent Influenza Vaccine (VaxigripTetra) in Children Aged 6 to 35 Months in South Korea
    Sunho Choe
    Oxana Talanova
    Sooyoun Shin
    Olga Syrkina
    Marion Fournier
    Infectious Diseases and Therapy, 2023, 12 : 1715 - 1723
  • [28] Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age
    Halasa, Natasha B.
    Gerber, Michael A.
    Berry, Andrea A.
    Anderson, Edwin L.
    Winokur, Patricia
    Keyserling, Harry
    Eckard, Allison Ross
    Hill, Heather
    Wolff, Mark C.
    McNeal, Monica M.
    Edwards, Kathryn M.
    Bernstein, David I.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2015, 4 (03) : 214 - 224
  • [29] Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons
    Claeys, Carine
    Zaman, Khalequ
    Dbaibo, Ghassan
    Li, Ping
    Izu, Allen
    Kosalaraksa, Pope
    Rivera, Luis
    Acosta, Beatriz
    Arroba Basanta, Maria Luisa
    Aziz, Asma
    Angel Cabanero, Miguel
    Chandrashekaran, Vijayalakshmi
    Corsaro, Bartholomew
    Cousin, Luis
    Diaz, Adolfo
    Diez-Domingo, Javier
    Dinleyici, Ener Cagri
    Faust, Saul N.
    Friel, Damien
    Garcia-Sicilia, Jose
    Gomez-Go, Grace D.
    Antoinette Gonzales, Maria Liza
    Hughes, Stephen M.
    Jackowska, Teresa
    Kant, Shashi
    Lucero, Marilla
    Malvaux, Ludovic
    Mares Bermudez, Josep
    Martinon-Torres, Federico
    Miranda, Mariano
    Montellano, May
    Peix Sambola, Maria Amor
    Prymula, Roman
    Puthanakit, Thanyawee
    Ruzkova, Renata
    Sadowska-Krawczenko, Iwona
    Salamanca de la Cueva, Ignacio
    Sokal, Etienne
    Soni, Jyoti
    Szymanski, Henryk
    Ulied, Angels
    Schuind, Anne
    Jain, Varsha K.
    Innis, Bruce L.
    LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (05) : 338 - 349
  • [30] Safety and persistence of immunological response 6 months after intramuscular vaccination with an AS03-adjuvanted H1N1 2009 influenza vaccine An open-label, randomized trial in Japanese children aged 6 months to 17 years
    Saitoh, Akihiko
    Nagai, Akira
    Tenjinbaru, Kazuyoshi
    Li, Ping
    Vaughn, David W.
    Roman, Francois
    Kato, Tatsuo
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (06) : 749 - 758